PET-CT in recurrent ovarian cancer: Impact on treatment planning

Anticancer Research

Volumn 28, Issue 4 C, 2008, Pages 2303-2308

  Lenhard, Miriam S ^a,b   Burges, Alexander ^a   Johnson, Thorsten R C ^a   Stieber, Petra ^a   Kümper, Carolin ^a   Ditsch, Nina ^a   Linke, Rainer ^a   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Computed tomography; Ovarian cancer; Positron emission tomography; Tumor marker

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FUROSEMIDE; IOPROMIDE; MANNITOL; SCOPOLAMINE BUTYL BROMIDE;

ADULT; AGED; ARTICLE; CANCER SURGERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; RECURRENT CANCER; RELAPSE; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 48849093887     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cannistra SA: Cancer of the ovary. N Engl J Med 329(21): 1550-1559, 1993.
2. Berek JS, Trope C and Vergote I: Surgery during chemotherapy and at relapse of ovarian cancer. Ann Oncol 10(Suppl 1): 3-7, 1999.
3. Hoskins WJ, Bundy BN, Thigpen JT and Omura GA: The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47(2): 159-166, 1992.
4. van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J and Pecorelli S: The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332(10): 629-634, 1995.
5. Rose PG, Nerenstone S, Brady MF, Clarke-Pearson D, Olt G, Rubin SC, Moore DH and Small JM: Secondary surgical cytoreduction for advanced ovarian carcinoma. N Engl J Med 351(24): 2489-2497, 2004.
6. Harter P, Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, Schroder W, Muenstedt K, Schmalfeldt B, Emons G, Pfisterer J, Wollschlaeger K, Meerpohl HG, Breitbach GP, Tanner B and Sehouli J: Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 13(12): 1702-1710, 2006.
7. Rustin GJ, Nelstrop AE, Tuxen MK and Lambert HE: Defining progression of ovarian carcinoma during follow-up according to CA 125: a North Thames Ovary Group Study. Ann Oncol 7(4): 361-364, 1996.
8. Buist MR, Golding RP, Burger CW, Vermorken JB, Kenemans P, Schutter EM, Baak JP, Heitbrink MA and Falke TH: Comparative evaluation of diagnostic methods in ovarian carcinoma with emphasis on CT and MRI. Gynecol Oncol 52(2): 191-198, 1994.
9. 18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 10(5): 761-767, 2000.
10. Schelling M, Avril N, Nahrig J, Kuhn W, Romer W, Sattler D, Werner M, Dose J, Janicke F, Graeff H and Schwaiger M: Positron emission tomography using [(18)F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 18(8): 1689-1695, 2000.
11. Bristow RE, Simpkins F, Pannu HK, Fishman EK and Montz FJ: Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer. Gynecol Oncol 85(1): 196-200, 2002.
12. Sironi S, Messa C, Mangili G, Zangheri B, Aletti G, Garavaglia E, Vigano R, Picchio M, Taccagni G, Maschio AD and Fazio F: Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologie findings. Radiology 233(2): 433-440, 2004.
13. 18F-FDG PET acquisition. J Nucl Med Technol 34(4): 228-231, 2006.
14. Herzog P, Scher B, Helmberger T, Hahn K, Reiser MF and Becker CR: PET-CT interventional tumour therapy. Radiologe 44(11): 1088-1095, 2004 (In German).
15. Simcock B, Neesham D, Quinn M, Drummond E, Milner A and Hicks RJ: The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol 103(1): 271-276, 2006.
16. Murakami M, Miyamoto T, Iida T, Tsukada H, Watanabe M, Shida M, Maeda H, Nasu S, Yasuda S, Yasuda M and Ide M: Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer. Int J Gynecol Cancer 16(Suppl 1): 99-107, 2006.
17. Garcia-Velloso MJ, Jurado M, Ceamanos C, Aramendia JM, Garrastachu MP, Lopez-Garcia G and Richter JA: Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma. Eur J Nucl Med Mol Imaging 34(9): 1396-1405 2007.
18. Bristow RE, del Carmen MG, Pannu HK, Cohade C, Zahurak ML, Fishman EK, Wahl RL and Montz FJ: Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Gynecol Oncol 90(3): 519-528, 2003.
19. Hauth EA, Antoch G, Stattaus J, Kuehl H, Veit P, Bockisch A, Kimmig R and Forsting M: Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer. Eur J Radiol 56(2): 263-268, 2005.
20. Pannu HK, Cohade C, Bristow RE, Fishman EK and Wahl RL: PET-CT detection of abdominal recurrence of ovarian cancer: radiologie-surgical correlation. Abdom Imaging 29(3): 398-403, 2004.
21. De Rosa V, Mangoni di Stefano ML, Brunetti A, Caraco C, Graziano R, Gallo MS and Maffeo A: Computed tomography and second-look surgery in ovarian cancer patients. Correlation, actual role and limitations of CT scan. Eur J Gynaecol Oncol 16(2): 123-129, 1995.
22. Makhija S, Howden N, Edwards R, Kelley J, Townsend DW and Meltzer CC: Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review. Gynecol Oncol 85(1): 53-58, 2002.